Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …

We are witnessing a revolution in our understanding of primary aldosteronism (PA). In the
past 2 decades, we have learned that PA is a highly prevalent syndrome that is largely …

Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

Context New approaches are needed to address the evolution of the primary aldosteronism
syndrome and to increase its recognition. Herein, we review evidence indicating that primary …

Background: With the widespread use of advanced imaging technology, adrenal tumors are
increasingly being identified. Objective: To investigate the prevalence and characteristics of …

Objective To assess the identification of primary aldosteronism (PA) in newly diagnosed,
treatment‐naïve patients with hypertension by screening in primary care. Design …

Importance Adrenal vein sampling (AVS) is the recommended procedure for subtyping
primary aldosteronism (PA) as unilateral PA (UPA) or bilateral PA (BPA), with different …

Primary aldosteronism, the most common secondary form of hypertension, is thought to be
present in≈ 5% to 10% of hypertensive adults. However, recent studies indicate that its …

Context The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio
(ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual …

Primary aldosteronism (PA) is a condition that is still largely overlooked, resulting in a
considerable burden of mortality and morbidity. This is despite decades of clinical and …